** = Publications listed in SCI/SSCI/Pubmed
** Moazedi-Fuerst, FC; Lackner, A; Kreuzer, SM; Eller, K; Odler, B; Kovacs, G; Flick, H; Talakic, E; Hermann, J; Venhoff, N; Venhoff, A; Hafner, F; Brodmann, M; Jud, P; Yazdani-Biuki, B; Husic, R; Salmhofer, W; Stradner, MH; Graninger, WB; Thiel, J; Brezinschek, HP
Successful long-term systemic sclerosis treatment by high-frequent low-dose B cell-depleting therapy.
J Autoimmun. 2024; 147: 103246
Doi: 10.1016/j.jaut.2024.103246
Web of Science
PubMed
FullText
FullText_MUG
** Dejaco, C; Mueller, T; Zamani, O; Kurtz, U; Egger, S; Resch-Passini, J; Totzauer, A; Yazdani-Biuki, B; Schwingenschloegl, T; Peichl, P; Kraus, A; Naerr, GW
A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study
FRONT MED-LAUSANNE. 2022; 9: 881943
Doi: 10.3389/fmed.2022.881943
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dejaco, C; Mueller, T; Zamani, O; Kurtz, U; Egger, S; Passini, JR; Totzauer, A; Eisterer, W; Yazdani-Biuki, B; Schwingenschloegl, T; Peichl, P; Kraus, A; Naerr, G; Rickert, V
Golimumab Improves Work Productivity and Activity As Well As Quality of Life in Patients with Rheumatoid Arthritis (RA), Psoriasis Arthritis (PsA) and Axial Spondyloarthritis (axSpA): Interim Results from a Non-Interventional Study in Austria (Go Active)
ARTHRITIS RHEUMATOL. 2018; 70: -ACR;
[Poster]
Web of Science
** Dejacol, C; Mueller, T; Zamani, O; Kurtz, U; Egger, S; Resch-Passini, J; Totzauer, A; Eisterer, W; Yazdani-Biuki, B; Schwingenschloegl, T; Peichl, P; Kraus, A; Naerr, GW; Rickert, V
GOLIMUMAB IMPROVES WORK PRODUCTIVITY AND ACTIVITY AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), PSORIASIS ARTHRITIS (PSA) AND AXIAL SPONDYLOARTHRITIS (AXSPA): INTERIM RESULTS FROM A NON-INTERVENTIONAL STUDY IN AUSTRIA (GO ACTIVE)
ANN RHEUM DIS. 2018; 77: 598-599.-Congress of the European-League-Against-Rheumatism (EULAR); JUN 13-16, 2018; Amsterdam, NETHERLANDS.
Doi: 10.1136/annrheumdis-2018-eular.2411
[Poster]
Web of Science
FullText
FullText_MUG
** Moazedi-Fuerst, FC; Kielhauser, SM; Scheidl, S; Tripolt, NJ; Lutfi, A; Yazdani-Biuki, B; Dejaco, C; Graninger, WB
Ultrasound screening for interstitial lung disease in rheumatoid arthritis.
Clin Exp Rheumatol. 2014; 32(2):199-203
Web of Science
PubMed
** Brickmann, K; Brezinschek, RI; Yazdani-Biuki, B; Graninger, WB; Brezinschek, HP
Superior specificity of anti-citrullinated peptide antibodies in patients with chronic lymphocytic leukemia and arthritis.
Clin Exp Rheumatol. 2011; 28(6):888-891
Web of Science
PubMed
** Yazdani-Biuki, B; Krippl, P; Brickmann, K; Fuerst, F; Langsenlehner, U; Paulweber, B; Pilger, E; Wascher, TC; Brezinschek, HP; Renner, W
The functional promoter polymorphism of the coagulation factor XII gene is not associated with peripheral arterial disease.
Angiology. 2010; 61(2):211-215
Doi: 10.1177/0003319709337305
Web of Science
PubMed
FullText
FullText_MUG
** Hofmann, G; Langsenlehner, U; Langsenlehner, T; Yazdani-Biuki, B; Clar, H; Gerger, A; Fuerst, F; Samonigg, H; Krippl, P; Renner, W
A common hereditary single-nucleotide polymorphism in the gene of FAS and colorectal cancer survival.
J Cell Mol Med. 2009; 13(9B):3699-3702
Doi: 10.1111/j.1582-4934.2009.00720.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Clar, H; Langsenlehner, U; Krippl, P; Renner, W; Leithner, A; Gruber, G; Hofmann, G; Yazdani-Biuki, B; Langsenlehner, T; Windhager, R
A polymorphism in the G protein beta3-subunit gene is associated with bone metastasis risk in breast cancer patients.
Breast Cancer Res Treat. 2008; 111(3):449-452
Doi: 10.1007/s10549-007-9808-0
Web of Science
PubMed
FullText
FullText_MUG
** Hofmann, G; Langsenlehner, U; Renner, W; Langsenlehner, T; Yazdani-Biuki, B; Clar, H; Gerger, A; Wehrschuetz, M; Samonigg, H; Krippl, P
Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk.
J Cancer Res Clin Oncol. 2008; 134(5):591-595
Doi: 10.1007/s00432-007-0322-x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Clar, H; Renner, W; Krippl, P; Leithner, A; Gruber, G; Langsenlehner, T; Hofmann, G; Yazdani-Biuki, B; Clar, V; Windhager, R; Langsenlehner, U
The LCT 13910 C/T polymorphism as a risk factor for osteoporosis, has no impact on metastatic bone disease in breast cancer.
Breast Cancer Res Treat. 2008; 112(2): 363-365.
Doi: 10.1007/s10549-007-9863-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Langsenlehner, T; Renner, W; Yazdani-Biuki, B; Langsenlehner, U
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Breast Cancer Res Treat. 2008; 107(3): 459-460.
Doi: 10.1007/s10549-007-9564-1
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Yazdani-Biuki, B; Brickmann, K; Langsenlehner, U; Renner, W; Truschnig, M; Krippl, P; Fürst, F; Graninger, WB; Brezinschek, HP
The Glu228Ala polymorphism in the ligand-binding domain of death receptor 4 is not associated with rheumatoid arthritis.
Ann Rheum Dis. 2008; 67(7): 1053-1054.
Doi: 10.1136/ard.2007.086124
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Fuerst, F; Stradner, M; Gruber, G; Angerer, H; Setznagel, D; Yazdani-Biuki, B; Windhager, R; Graninger, W
Treatment with 5-AZA-deoxy-cytidine in human arthritic cartilage cells increases the gene expression of MMP-13, BMP-1, chondromodulin-1 and ELK-1.
ANN RHEUM DIS. 2008; 67: A40-A41.-EULAR; Paris, FRANCE.
[Poster]
Web of Science
** Gerger, A; Langsenlehner, U; Renner, W; Weitzer, W; Eder, T; Yazdani-Biuki, B; Hofmann, G; Samonigg, H; Krippl, P
A multigenic approach to predict breast cancer risk.
Breast Cancer Res Treat. 2007; 104(2):159-164
Doi: 10.1007/s10549-006-9408-4
Web of Science
PubMed
FullText
FullText_MUG
** Hermann, J; Müller, T; Yazdani-Biuki, B; Aringer, M; Herold, M; Ebner, W; Ofner, P; Graninger, W
High disease activity of ankylosing spondylitis in the community before the introduction of tumour necrosis factor blockers.
ANN RHEUM DIS. 2007; 66(4): 561-562.
Doi: 10.1136/ard.2006.060061
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Brickmann, K; Yazdani-Biuki, BJ; Eibinger, C; Graninger, WB; Brezinschek, HR
Determination of rheumatoid factors (RF) and anti cyclic citruillinated peptide antibodies (anti-CCP) in synovial fluid provides no additional information
ANN RHEUM DIS. 2007; 66: 561-561.-EULAR Annual Scientific Meeting; JUN 13-16, 2007; Barcelona, SPAIN.
[Poster]
Web of Science
** Brickmann, KS; Yazdani-Biuki, BJ; Brezinschek, RI; Graninger, WB; Brezinschek, HP
Sequential etanercept and rituximab therapy in patients with active RA-SERRA
ARTHRITIS RHEUM. 2007; 56(12):4278-4278.-ACR Annual Scientific Meeting; NOV 6-11, 2007; Boston, USA.
[Poster]
Web of Science
** Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Eder, T; Wascher, TC; Paulweber, B; Clar, H; Hofmann, G; Samonigg, H; Krippl, P
Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
Breast Cancer Res Treat. 2006; 97(1):67-72
Doi: 10.1007/s10549-005-9089-4
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Langsenlehner, U; Yazdani-Biuki, B; Eder, T; Renner, W; Wascher, TC; Paulweber, B; Weitzer, W; Samonigg, H; Krippl, P
The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk.
Clin Cancer Res. 2006; 12(4):1392-1394
Doi: 10.1158/1078-0432.CCR-05-2055
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Yazdani-Biuki, B; Brickmann, K; Wohlfahrt, K; Mueller, T; März, W; Renner, W; Gutjahr, M; Langsenlehner, U; Krippl, P; Wascher, TC; Paulweber, B; Graninger, W; Brezinschek, HP
The MHC2TA -168A>G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients.
Arthritis Res Ther. 2006; 8(4):R97-R97
Doi: 10.1186/ar1974
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Yazdani-Biuki, B; Mueller, T; Brezinschek, HP; Hermann, J; Graninger, W; Wascher, TC
Relapse of diabetes after interruption of chronic administration of anti-tumor necrosis factor-alpha antibody infliximab: a case observation.
Diabetes Care. 2006; 29(7): 1712-1713.
Doi: 10.2337/dc06-0636
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Brezinschek, HP; Brickmann, K; Yazdani-Biuki, B; Dörner, T; Graninger, WB; Brezinschek, RI
Treatment of rheumatoid arthritis in the 21st century: targeting B-lymphocytes.
Wien Med Wochenschr. 2006; 156(1-2): 61-67.
Doi: 10.1007/s10354-005-0241-x
PubMed
FullText
FullText_MUG
Google Scholar
** Brickmann, KP; Yazdani-Biuki, BJ; Graninger, M; Brezinschek, RI; Stoiser, E; Graninger, WB; Brezinschek, HP
Autoantibodies against mutated citrullinated Vimentin (anti-MCV) in the elderly population
ANN RHEUM DIS. 2006; 65: 580-581.-Annual European Congress of Rheumatology (EULAR 2006); JUN 21-24, 2006; Amsterdam, NETHERLANDS.
Web of Science
** Yazdani-Biuki, BJ; Brickmann, K; Brezinschek, RI; Muller, T; Graninger, W; Brezinschek, H
The positive predictive value of anti-cyclic citrullinated peptide antibodies for rheumatoid arthritis compared with psoriatic arthritis and chronic lymphocytic B-cell leukemia
ANN RHEUM DIS. 2006; 65: 159-159.-Annual European Congress of Rheumatology (EULAR 2006); JUN 21-24, 2006; Amsterdam, NETHERLANDS.
Web of Science
** Bahadori, B; Yazdani-Biuki, B; Krippl, P; Brath, H; Uitz, E; Wascher, TC
Low-fat, high-carbohydrate (low-glycaemic index) diet induces weight loss and preserves lean body mass in obese healthy subjects: results of a 24-week study.
Diabetes Obes Metab. 2005; 7(3):290-293
Doi: 10.1111/j.1463-1326.2004.00445.x
Web of Science
PubMed
FullText
FullText_MUG
** Langsenlehner, U; Krippl, P; Renner, W; Yazdani-Biuki, B; Eder, T; Köppel, H; Wascher, TC; Paulweber, B; Samonigg, H
Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk.
Breast Cancer Res Treat. 2005; 90(2):113-115
Doi: 10.1007/s10549-004-3607-7
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Yazdani-Biuki, B; Stadlmaier, E; Mulabecirovic, A; Brezinschek, R; Tilz, G; Demel, U; Mueller, T; Brickmann, K; Graninger, WB; Brezinschek, HP
Blockade of tumour necrosis factor {alpha} significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis.
Ann Rheum Dis. 2005; 64(8):1224-1226
Doi: 10.1136/ard.2004.030262
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Brickmann, KS; Yazdani-Biuki, BJ; Brezinschek, RI; Mulabecirovic, A; Graninger, WB; Dorner, T; Brezinschek, H
Different reading frame usage of variable heavy chain diversity segments in patients with systemic lupus erythematosus and rheumatoid arthritis
ANN RHEUM DIS 2005 64: 229-229.
[Poster]
Web of Science
** Yazdani-Biuki, BJ; Mueller, T; Brezinschek, H; Graninger, WB; Pilger, E; Brodmann, M
Seasonal variation in acute phase proteins in patients with primary Raynaud's phenomenon
ANN RHEUM DIS 2005 64: 300-300.
[Poster]
Web of Science
** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Köppel, H; Leithner, A; Wascher, TC; Paulweber, B; Samonigg, H
The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Clin Cancer Res. 2004; 10(10):3518-3520
Doi: 10.1158/1078-0432.CCR-04-0010
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Samonigg, H
The 825C>T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer.
CANCER LETT. 2004; 206(1): 59-62.
Doi: 10.1016/j.canlet.2003.11.030
Web of Science
PubMed
FullText
FullText_MUG
** Langsenlehner, U; Krippl, P; Renner, W; Yazdani-Biuki, B; Eder, T; Wolf, G; Wascher, TC; Paulweber, B; Weitzer, W; Samonigg, H
Genetic variants of the sulfotransferase 1A1 and breast cancer risk.
Breast Cancer Res Treat. 2004; 87(1):19-22
Doi: 10.1023/B:BREA.0000041574.90735.ea
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Wolf, G; Aigner, RM; Schaffler, G; Langsenlehner, U; Renner, W; Samonigg, H; Yazdani-Biuki, B; Krippl, P
The 936C>T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake.
BREAST CANCER RES TREAT. 2004; 88(3): 205-208.
Doi: 10.1007/s10549-004-0724-2
Web of Science
PubMed
FullText
FullText_MUG
** Yazdani-Biuki, B; Stelzl, H; Brezinschek, HP; Hermann, J; Mueller, T; Krippl, P; Graninger, W; Wascher, TC
Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab.
EUR J CLIN INVEST. 2004; 34(9): 641-642.
Doi: 10.1111/j.1365-2362.2004.01390.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Hermann, J; Mueller, T; Yazdani-Biuki, B; Graninger, W
Disease activity and functional impairment of patients with ankylosing spondylitis in Austria - An epidemiologic survey
ANN RHEUM DIS 2004 63: 395-396.
[Poster]
Web of Science
** Yazdani-Biuki, B; Wohlfahrt, K; Mueller, T; Mulabecirovic, A; Brezinschek, RI; Graninger, WB; Brezinschek, HP
A modified disease activity score with fibrinogen as a tool for the assesment of disease activity in patients with rheumatoid arthritis
ARTHRITIS RHEUM 2004 50: S164-S164.
Web of Science
** Yazdani-Biuki, BJ; Mulabecirovic, A; Mueller, T; Hermann, J; Graninger, WB; Brezinschek, H
Significant increase of IGG- and IGA-rheumatoid factor in patients with rheumatoid arthritis during prolonged treatment with etanercept
ANN RHEUM DIS 2004 63: 140-140.
[Poster]
Web of Science
** Yazdani-Biuki, B; Wohlfahrt, K; Mulabecirovic, A; Mueller, T; Hermann, J; Graninger, WB; Brezinschek, HP; Brezinschek, RI
Long term treatment of psoriatic arthritis with infliximab.
ANN RHEUM DIS. 2004; 63(11): 1531-1532.
[OPEN ACCESS]
Web of Science
PubMed
FullText
** Bahadori, B; Trinker, M; Wallner, SJ; Yazdani-Biuki, B; Wascher, TC
Diabetes mellitus and weight control: differences of respiratory quotient in type 2 diabetic obese subjects receiving sulfonylureas and non-diabetic obese controls.
Nutrition. 2003; 19(2):159-160
Doi: 10.1016%2FS0899-9007%2802%2901063-8
Web of Science
PubMed
FullText
FullText_MUG
** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Bahadori, B; Samonigg, H
The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk.
Cancer Lett. 2003; 201(2):181-184
Doi: 10.1016/S0304-3835(03)00468-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Haas, J; Samonigg, H
A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk.
Int J Cancer. 2003; 106(4):468-471
Doi: 10.1002/ijc.11238
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Weitzer, W; Leithner, A; Samonigg, H
The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer.
Breast Cancer Res Treat. 2003; 82(3):165-168
Doi: 10.1023/B:BREA.0000004372.20461.33
Web of Science
PubMed
FullText
FullText_MUG
** Langsenlehner, U; Krippl, P; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Weitzer, W; Samonigg, H
The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk.
Breast Cancer Res Treat. 2003; 81(2):169-172
Doi: 10.1023/A:1025752420309
Web of Science
PubMed
FullText
FullText_MUG
** Mulabecirovic, A; Yazdani-Biuki, B; Brezinschek, R; Muller, T; Hermann, J; Brezinschek, HP
Superantigen seems to shape the naive synovial tissue B cell repertoire in rheumatoid arthritis
ANN RHEUM DIS 2003 62: 141-141.
Web of Science
** Muller, T; Liebscher, B; Yazdani-Biuki, B; Eder, S; Gretler, J; Brezinschek, H; Hermann, J
Efficacy and safety of leflunomide in rheumatoid arthritis patients treated in an outpatient clinic
ANN RHEUM DIS 2003 62: 423-423.
Web of Science
** Stadlmaier, E; Yazdani-Biuki, B; Hermann, J
Influence of a therapy with tumor necrosis factor alpha inhibiting substances on B cell function in rheumatoid arthritis
ANN RHEUM DIS 2003 62: 174-174.
Web of Science
** Yazdani-Biuki, B; Bahadori, B; Mulabecirovic, A; Brezinschek, R; Brezinschek, HP
Isoprostane as a marker of disease activity in SLE patients.
ARTHRITIS RHEUM 2003 48: 1488-1488.
Web of Science
** Yazdani-Biuki, B; Brezinschek, RJ; Gretler, J; Eder, S; Mueller, T; Hermann, J; Mulabecirovic, A; Krappinger, A; Stadlmaier, E; Uitz, E; Brezinschek, HP
Comparison of antibody titers with sledai, modified SLEDAI and ECLAM in SLE patients
ANN RHEUM DIS 2003 62: 435-435.
Web of Science
** Mueller, TJ; Hermann, J; Fahrleitner, A; Yazdani-Biuki, B; Dimai, HP
Effects of the anti-TNF-antibody infliximab on markers of bone turnover in patients with rheumatoid arthritis.
ARTHRITIS RHEUM. 2001; 44(9): S232-S232.
Web of Science
** Yazdani-Biuki, B; Brezinschek, R; Dorner, T; Jakobi, AM; Hermann, J; Muller, T; Eder, S; Gretler, J; Fuchshofer, A; Brezinschek, HP
Naive B cells in SLE preferentially utilize diversity gene segments in reading frames encoding hydrophobic amino acids
J RHEUMATOL. 2001; 28: 87-87.
Web of Science
** Yazdani-Biuki, BJ; Brezinschek, RI; Doerner, T; Jakobi, AM; Maizen, C; Brezinschek, HP
Preferential utilization of D segments in hydrophobic reading frames in antibodies is a specific feature of SLE but not RA or normal B-cells.
ARTHRITIS RHEUM. 2001; 44(9): S76-S76.
Web of Science